A comprehensive view of Liver / Kidney / Bladder Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZenica's Imfinzi plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase 3 trial
Published: April 16, 2024 by AstraZeneca AB
Abbott Laboratories Seeks Patent for HBV Diagnostic, Prognostic and Therapeutic Methods and Products
Published: April 16, 2024 by Pharmaceutical Patent News
AstraZeneca's IMPACT CKD model predicts chronic kidney disease could impact up to 16.5% of population across US, Brazil, UK, Spain, Germany, Netherlands, China, and Australia by 2032; advanced stages could increase by 59.3%
Published: April 15, 2024 by AstraZeneca AB
Olympus reports positive policy changes by commercial payers is extending coverage for iTind, its minimally invasive treatment for benign prostatic hyperplasia; policy updates may affect up to 27 million enrollees in the US
Published: April 15, 2024 by Olympus America Inc.
CA ACR173: APOL1-Mediated Kidney Disease (AMKD) Awareness Day.
Published: April 09, 2024 by California 2023-2024 Session

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count